EYE vs DRVN vs NVST vs MNRO vs XRAY

For growth investors, National Vision Holdings, Inc.

(EYE) is the stronger pick with 9. 0% revenue growth year-over-year, versus -6. 4% for Monro, Inc. (MNRO). National Vision Holdings, Inc. (EYE) offers the better valuation at 61. 7x trailing P/E (32. 6x forward), making it the more compelling value choice. Analysts rate National Vision Holdings, Inc. (EYE) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, National Vision Holdings, Inc.

(EYE) is the cheapest at 61. 7x versus Envista Holdings Corp at 86. 7x. On forward P/E, DENTSPLY SIRONA Inc. is actually cheaper at 7. 7x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Envista Holdings Corp (NVST) delivered a total return of -46.

6%, compared to -80. 1% for DENTSPLY SIRONA Inc. (XRAY). Over 10 years, the gap is even starker: NVST returned -13. 1% versus XRAY's -74. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Driven Brands Holdings Inc.

(DRVN) is the lower-risk stock at 0. 68β versus DENTSPLY SIRONA Inc. 's 1. 78β — meaning XRAY is approximately 161% more volatile than DRVN relative to the S&P 500. On balance sheet safety, Envista Holdings Corp (NVST) carries a lower debt/equity ratio of 55% versus 7% for Driven Brands Holdings Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), National Vision Holdings, Inc.

(EYE) is pulling ahead at 9. 0% versus -6. 4% for Monro, Inc. (MNRO). On earnings-per-share growth, the picture is similar: National Vision Holdings, Inc. grew EPS 202. 8% year-over-year, compared to -119. 3% for Monro, Inc.. Over a 3-year CAGR, DRVN leads at 16. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Envista Holdings Corp (NVST) is the more profitable company, earning 1.

7% net margin versus -16. 3% for DENTSPLY SIRONA Inc. — meaning it keeps 1. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NVST leads at 8. 3% versus -6. 0% for DRVN. At the gross margin level — before operating expenses — NVST leads at 55. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, DENTSPLY SIRONA Inc.

(XRAY) trades at 7. 7x forward P/E versus 32. 6x for National Vision Holdings, Inc. — 24. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MNRO: 129. 5% to $40. 00.

In this comparison, MNRO (6.

4% yield), XRAY (5. 9% yield) pay a dividend. EYE, DRVN, NVST do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Driven Brands Holdings Inc.

(DRVN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 68)). Envista Holdings Corp (NVST) carries a higher beta of 1. 65 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (DRVN: -48. 5%, NVST: -13. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (EYE (Consumer Cyclical) and DRVN (Consumer Cyclical) and NVST (Healthcare) and MNRO (Consumer Cyclical) and XRAY (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: EYE is a small-cap quality compounder stock; DRVN is a small-cap quality compounder stock; NVST is a small-cap quality compounder stock; MNRO is a small-cap income-oriented stock; XRAY is a small-cap income-oriented stock. MNRO, XRAY pay a dividend while EYE, DRVN, NVST do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.